Alto Neuroscience, Inc. (ANRO) Stock Statistics & Valuation Metrics

Alto Neuroscience, Inc. has a market cap or net worth of $572.55M. The enterprise value is -$60.72M.

Alto Neuroscience, Inc. has 31,066,336 shares outstanding. The number of shares has decreased by -2.65% in one year.

Alto Neuroscience, Inc.’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -40.74%.

The current PE Ratio of Alto Neuroscience, Inc. is ―. Alto Neuroscience, Inc.’s PEG ratio is -0.02.

In the last 12 months, Alto Neuroscience, Inc. had revenue of 0.00 and earned -61.43M in profits. Earnings per share was -2.50.

In the last 12 months, operating cash flow was -53.27M and capital expenditures -530.00K, giving a free cash flow of -53.80M billion.

Alto Neuroscience, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Alto Neuroscience, Inc. upcoming earnings date is May 20, 2026, After Close (Confirmed).

Alto Neuroscience, Inc. as a current ratio of 16.92, with Debt / Equity ratio of 3.41%

In the past 12 months, Alto Neuroscience, Inc. has paid 0.00 in taxes.

Alto Neuroscience, Inc. EV to EBITDA ratio is 0.69, with an EV/FCF ratio of 0.95.

Alto Neuroscience, Inc. has $137.82M in cash and marketable securities with $27.52M in debt, giving a net cash position of $110.29M billion.

Gross margin is -69.54%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Alto Neuroscience, Inc. is $30.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy